Veru Inc. (VERU:NASDAQ) soared at $15.57, representing a gain of 21.9%. The stock appeared on our News Catalysts scanner on Thu, Sep 08, 2022 at 10:27 AM in the 'BIOTECH' category. From Fri, Aug 26, 2022, the stock recorded 33.33% Up Days and 60.00% Green Days
The stock spiked on Wed, Aug 17, 2022 at $24.55 with a volume of 12M+.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- Digital Media Solutions Inc. Class A (DMS:NYSE), 71.88%
- Aditxt Inc. (ADTX:NASDAQ), 37%
- Trinity Place Holdings Inc. (TPHS:NYSEMKT), 33.79%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 31.09%
- MOGU Inc. (MOGU:NYSE), 29.82%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 26.14%
- Invitae Corporation (NVTA:NYSE), 25%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 24.24%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 22.77%
- Veru Inc. (VERU:NASDAQ), 21.93%